Pharmafile Logo
Pharmafocus logo
Advanced Search
janssen_latest_logo_on_sign_closer

SMC rejects Janssen’s multiple myeloma treatment Darzalex

January 17, 2017
Manufacturing and Production, Sales and Marketing Janssen, SMC, darzalex

The Scottish Medicines Consortium (SMC) has decided not to recommend Janssen’s Darzalex (daratumumab) for routine use by NHS Scotland as …

News
mr058666-web

Merck forges data analytics partnership with Palantir

January 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …

News

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …

News
bia

New NICE ultra-rare disease proposals “not fit for purpose”, says BIA

January 16, 2017
Manufacturing and Production BioIndustry Association, NICE

The BioIndustry Association (BIA) has accused new proposals put forward by the National Institute for Health and Care Excellence (NICE) …

News
researchers_credit_neusentis_pfizer

Benzodiazepines increase stroke risk in Alzheimer’s patients, study finds

January 16, 2017
Research and Development, Sales and Marketing Alzheimer's, Alzheimers, benzodiazepines

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …

News
jj_sign_on_wall

J&J to reveal drug price increases next month

January 16, 2017
Sales and Marketing Johnson & Johnson

Next month, Johnson & Johnson will reveal the average price increases of its prescription drugs in a move to increase …

News
novo_nordisk_flag

Novo strikes up personalised diabetes treatment deal with Glooko

January 16, 2017
Sales and Marketing Glooko, Novo Nordisk, ibm

Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with …

News
mr058666-web

Merck in $230 million swoop for Vertex cancer programmes

January 16, 2017
Sales and Marketing Vertex

Merck has completed a deal with Boston-based biotech firm Vertex Pharmaceuticals for the rights to four cancer programmes worth $230 …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

News
mauriciof-269

Advancing the Pharmaceutical Supply Chain

January 13, 2017
Manufacturing and Production, Medical Communications Janssen, batch manufacturing, continuous manufacturing

Mauricio Futran, vice president, Process Sciences, Janssen Supply Chain, discusses, in the latest issue of Pharmafile, Janssen’s move into continuous …

News
lillycorporatehq

Lilly three strikes in three years not out in Teva patent challenge

January 13, 2017
Medical Communications, Sales and Marketing Eli Lilly, Teva, generics, lilly, patent

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …

News

NICE recommends Novartis’ previously CDF-exclusive kidney cancer treatment

January 13, 2017
Medical Communications, Sales and Marketing Afinitor, CDF, NICE, Novartis, everolimus

In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …

News
wales_flag

Welsh government launches £80 million fund for newly approved drugs

January 13, 2017
Medical Communications Wales, Welsh Government, drug fund

The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …

News
1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017
Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

News

IBM and FDA collaborate to protect patient data with blockchain technology

January 12, 2017
Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …

News
entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017
Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …

News
biocon_office

Mylan and Biocon apply to FDA for biosimilar approval

January 12, 2017
Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab

Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …

News
shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

News

New immunotherapy-based cancer research limits cancer spread by 75%

January 12, 2017
Medical Communications, Research and Development Cancer, cancer research, immunotherapy

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

News
riodejaneiro_aerea_aeroportogaleao-131756cut

Rio De Janeiro’s primary airport awarded CEIV Pharma certification

January 11, 2017
Manufacturing and Production Rio Galeao, cargo

Rio Galeão, the main airport serving Rio De Janeiro, has been awarded Centre of Excellence for Independent Validators (CEIV) Pharma …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026